Psychiatric manifestations of Anti-NMDA receptor encephalitis: Neurobiological underpinnings and differential diagnostic implications

Psychosomatics

Volumn 55, Issue 1, 2014, Pages 37-44

  Maneta, Eleni ^a   Garcia, Georgina ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLPREDNISOLONE; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ANTI N METHYL D ASPARTATE RECEPTOR ENCEPHALITIS; ANXIETY; CATATONIA; CLINICAL FEATURE; DIFFERENTIAL DIAGNOSIS; DYSTONIA; ELECTROCONVULSIVE THERAPY; FEVER; FLU LIKE SYNDROME; GENE; GRANDIOSE DELUSION; HEADACHE; HUMAN; IMMUNOTHERAPY; INSOMNIA; MAJOR DEPRESSION; NAUSEA; NEUROBIOLOGY; NRG1 GENE; PATHOPHYSIOLOGY; PSYCHOSIS; REVIEW; SCHIZOPHRENIA; SEIZURE; SYMPTOMATOLOGY; TREATMENT OUTCOME; ANTI-N-METHYL-D-ASPARTATE RECEPTOR ENCEPHALITIS; PSYCHOLOGY; PSYCHOTIC DISORDERS;

ANTI-N-METHYL-D-ASPARTATE RECEPTOR ENCEPHALITIS; DIAGNOSIS, DIFFERENTIAL; HUMANS; PSYCHOTIC DISORDERS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 84891372493     PISSN: 00333182     EISSN: 15457206     Source Type: Journal    
DOI: 10.1016/j.psym.2013.06.002     Document Type: Review

References (52)

1. Dalmau J., Tuzun E., Wu H.Y., et al. Paraneoplastic anti-N-methyl-d-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007, 61:25-36.
2. Dalmau J., Lancaster E., Martinez-Hernandez E., Rosenfeld M.R., Balice-Gordon R. Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis. Lancet Neurol 2011, 10:63-74.
3. Lebas A., Husson B., Didelot A., Honnorat J., Tardieu M. Expanding spectrum of encephalitis with NMDA receptor antibodies in young children. J Child Neurol 2010, 25:742-745.
4. Varvat J., Lafond P., Page Y., Coudrot M., Reynaud-Salard M., Tardy B. Acute psychiatric syndrome leading young patients to ICU: consider anti-NMDA-receptor antibodies. Anaesth Intensive Care 2010, 38:748-750.
5. Maggina P., Mavrikou M., Karagianni S., et al. Anti-N-methyl-d-aspartate receptor encephalitis presenting with acute psychosis in a preteenage girl: a case report. J Med Case Rep 2012, 6:224.
6. Yu A.Y., Moore F.G. Paraneoplastic encephalitis presenting as postpartum psychosis. Psychosomatics 2011, 52:568-570.
7. Caplan J.P., Binius T., Lennon V.A., Pittock S.J., Rao M.S. Pseudopseudoseizures: conditions that may mimic psychogenic non-epileptic seizures. Psychosomatics 2011, 52:501-506.
8. Wandinger K.-P., Saschenbrecker S., Stoecker W., Dalmau J. Anti-NMDA-receptor encephalitis: a severe, multistage, treatable disorder presenting with psychosis. J Neuroimmunol 2011, 231:86-91.
9. Mann A., Machado N.M., Liu N., Mazin A.H., Silver K., Afzal K.I. A multidisciplinary approach to the treatment of anti-NMDA-receptor antibody encephalitis: a case and review of the literature. J Neuropsychiatry Clin Neurosci 2012, 24:247-254.
10. Eker A., Saka E., Dalmau J., et al. Testicular teratoma and anti-N-methyl-d-aspartate receptor-associated encephalitis. J Neurol Neurosurg Psychiatry 2008, 79:1082-1083.
11. Dalmau J., Gleichman A.J., Hughes E.G., et al. Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008, 7:1091-1098.
12. Florance N.R., Davis R.L., Lam C., et al. Anti-N-methyl-d-aspartate receptor (NMDAR) encephalitis in children and adolescents. Ann Neurol 2009, 66:11-18.
13. Gable M.S., Sheriff H., Dalmau J., Tilley D.H., Glaser C.A. The frequency of autoimmune N-methyl-d-aspartate receptor encephalitis surpasses that of individual viral etiologies in young individuals enrolled in the California Encephalitis Project. Clin Infect Dis 2012, 54:899-904.
14. Barry H., Hardiman O., Healy D.G., et al. Anti-NMDA receptor encephalitis: an important differential diagnosis in psychosis. Br J Psychiatry 2011, 199:508-509.
15. Sansing L.H., Tuzun E., Ko M.W., Baccon J., Lynch D.R., Dalmau J. A patient with encephalitis associated with NMDA receptor antibodies. Nat Clin Pract Neurol 2007, 3:291-296.
16. Pillai S.C., Gill D., Webster R., Howman-Giles R., Dale R.C. Cortical hypometabolism demonstrated by PET in relapsing NMDA receptor encephalitis. Pediatr Neurol 2010, 43:217-220.
17. Maeder-Ingvar M., Prior J.O., Irani S.R., Rey V., Vincent A., Rossetti A.O. FDG-PET hyperactivity in basal ganglia correlating with clinical course in anti-NDMA-R antibodies encephalitis. J Neurol Neurosurg Psychiatry 2011, 82:235-236.
18. Chapman M.R., Vause H.E. Anti-NMDA receptor encephalitis: diagnosis, psychiatric presentation, and treatment. Am J Psychiatry 2011, 168:245-251.
19. Lee A., Glick D.B., Dinwiddie S.H. Electroconvulsive therapy in a pediatric patient with malignant catatonia and paraneoplastic limbic encephalitis. J ECT 2006, 22:267-270.
20. Iwata M., Hazama G.I., Nakagome K. Depressive state due to isolated adrenocorticotropic hormone deficiency underlies school refusal. Psychiatry Clin Neurosci 2012, 66:243-244.
21. Braakman H.M.H., Moers-Hornikx V.M.P., Arts B.M.G., Hupperts R.M.M., Nicolai J. Pearls & Oy-sters: Electroconvulsive therapy in anti-NMDA receptor encephalitis. Neurology 2010, 75:e44-e46.
22. Grover S., Mattoo S.K., Gupta N. Theories on mechanism of action of electroconvulsive therapy. German J Psychiatry 2005, 8:70-84.
23. Watkins C.J., Pei Q., Newberry N.R. Differential effects of electroconvulsive shock on the glutamate receptor mRNAs for NR2A, NR2B and mGluR5b. Brain Res Mol Brain Res 1998, 61:108-113.
24. Titulaer M.J., McCracken L., Gabilondo I., et al. Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study. Lancet Neurol 2013, 12:157-165.
25. Corlew R., Brasier D.J., Feldman D.E., Philpot B.D. Presynaptic NMDA receptors: newly appreciated roles in cortical synaptic function and plasticity. Neuroscientist 2008, 14:609-625.
26. Cull-Candy S., Brickley S., Farrant M. NMDA receptor subunits: diversity, development and disease. Curr Opin Neurobiol 2001, 11:327-335.
27. Steffens M., Huppertz H.J., Zentner J., Chauzit E., Feuerstein T.J. Unchanged glutamine synthetase activity and increased NMDA receptor density in epileptic human neocortex: implications for the pathophysiology of epilepsy. Neurochem Int 2005, 47:379-384.
28. Sachdev P.S. Alternating and postictal psychoses: review and a unifying hypothesis. Schizophr Bull 2007, 33:1029-1037.
29. Northoff G. What catatonia can tell us about "top-down modulation": a neuropsychiatric hypothesis. Behav Brain Sci. 2002; 25: 555-577; [discussion 78-604].
30. Northoff G., Eckert J., Fritze J. Glutamatergic dysfunction in catatonia? Successful treatment of three acute akinetic catatonic patients with the NMDA antagonist amantadine. J Neurol Neurosurg Psychiatry 1997, 62:404-406.
31. Olney J.W., Newcomer J.W., Farber N.B. NMDA receptor hypofunction model of schizophrenia. J Psychiatr Res 1999, 33:523-533.
32. Moghaddam B., Adams B., Verma A., Daly D. Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex. J Neurosci 1997, 17:2921-2927.
33. Kantrowitz J.T., Javitt D.C. N-methyl-d-aspartate (NMDA) receptor dysfunction or dysregulation: the final common pathway on the road to schizophrenia?. Brain Res Bull 2010, 83:108-121.
34. Carroll B.T., Goforth H.W., Thomas C., et al. Review of adjunctive glutamate antagonist therapy in the treatment of catatonic syndromes. J Neuropsychiatry Clin Neurosci 2007, 19:406-412.
35. Fumagalli F., Molteni R., Roceri M., et al. Effect of antipsychotic drugs on brain-derived neurotrophic factor expression under reduced N-methyl-d-aspartate receptor activity. J Neurosci Res 2003, 72:622-628.
36. Coyle J.T., Tsai G. NMDA receptor function, neuroplasticity, and the pathophysiology of schizophrenia. Int Rev Neurobiol 2004, 59:491-515.
37. Javitt D.C. Glutamate and schizophrenia: phencyclidine, N-methyl-d-aspartate receptors, and dopamine-glutamate interactions. Int Rev Neurobiol 2007, 78:69-108.
38. Carlsson A., Lindqvist M. Effect of chlorpromazine or haloperidol on formation of 3methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol Toxicol 1963, 20:140-144.
39. Carlsson A. The neurochemical circuitry of schizophrenia. Pharmacopsychiatry 2006, 39(1 Suppl):S10-S14.
40. Stephan K.E., Friston K.J., Frith C.D. Dysconnection in schizophrenia: from abnormal synaptic plasticity to failures of self-monitoring. Schizophr Bull 2009, 35:509-527.
41. O'Tuathaigh C.M., Babovic D., O'Meara G., Clifford J.J., Croke D.T., Waddington J.L. Susceptibility genes for schizophrenia: characterisation of mutant mouse models at the level of phenotypic behaviour. Neurosci Biobehav Rev 2007, 31:60-78.
42. Zandi M.S., Irani S.R., Lang B., et al. Disease-relevant autoantibodies in first episode schizophrenia. J Neurol 2011, 258:686-688.
43. Tsutsui K., Kanbayashi T., Tanaka K., et al. Anti-NMDA-receptor antibody detected in encephalitis, schizophrenia, and narcolepsy with psychotic features. BMC Psychiatry 2012, 12:37.
44. Steiner J., Walter M., Glanz W., et al. Increased prevalence of diverse N-Methyl-d-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-Methyl-d-aspartate glutamate receptor encephalitis. JAMA Psychiatry 2013, 70:1-8.
45. Potvin S., Stip E., Sepehry A.A., Gendron A., Bah R., Kouassi E. Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol Psychiatry 2008, 63:801-808.
46. Jones A.L., Mowry B.J., Pender M.P., Greer J.M. Immune dysregulation and self-reactivity in schizophrenia: do some cases of schizophrenia have an autoimmune basis?. Immunol Cell Biol 2005, 83:9-17.
47. Abbott N.J., Ronnback L., Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 2006, 7:41-53.
48. Brown A.S. Prenatal infection as a risk factor for schizophrenia. Schizophr Bull 2006, 32:200-202.
49. Meyer U., Feldon J. Epidemiology-driven neurodevelopmental animal models of schizophrenia. Prog Neurobiol 2010, 90:285-326.
50. Moreno J.L., Kurita M., Holloway T., et al. Maternal influenza viral infection causes schizophrenia-like alterations of 5-HT(2)A and mGlu(2) receptors in the adult offspring. J Neurosci 2011, 31:1863-1872.
51. Homayoun H., Jackson M.E., Moghaddam B. Activation of metabotropic glutamate 2/3 receptors reverses the effects of NMDA receptor hypofunction on prefrontal cortex unit activity in awake rats. J Neurophysiol 2005, 93:1989-2001.
52. Lennox B.R., Coles A.J., Vincent A. Antibody-mediated encephalitis: a treatable cause of schizophrenia. Br J Psychiatry 2012, 200:92-94.